# Effectiveness of Combination of Arimidex and Nolvadex in Adjuvant Therapy of Breast Carcinoma in Postmenopausal Women.

> **NCT00287534** · PHASE2 · COMPLETED · sponsor: **AstraZeneca** · enrollment: 1059 (estimated)

## Conditions studied

- Breast Cancer

## Interventions

- **DRUG:** Anastrozole
- **DRUG:** Tamoxifen

## Key facts

- **NCT ID:** NCT00287534
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1996-11
- **Primary completion:** —
- **Final completion:** 2004-09
- **Target enrollment:** 1059 (ESTIMATED)
- **Last updated:** 2009-06-09

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00287534

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00287534, "Effectiveness of Combination of Arimidex and Nolvadex in Adjuvant Therapy of Breast Carcinoma in Postmenopausal Women.". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT00287534. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*